Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › organ transplant

organ transplant

Nov 19, 2020

CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests

The company's AlloSure Kidney test received coverage, along with its AlloSure Heart test when used with the firm's AlloMap test.

Nov 06, 2020

Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests

Premium

The company plans to show new data for its Signatera oncology test at three upcoming conferences this year, including in breast cancer and bladder cancer.

Nov 05, 2020

Natera Q3 Revenues Up 26 Percent on Increased Testing Volumes

Product revenues increased 39 percent year over year to $93.3 million, while license and other revenues were down 56 percent to $4.9 million.

Nov 03, 2020

Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection

Premium

The firm recently described circumstances in which the fraction of host or donor DNA could be altered, and plans new approaches to data interpretation.

Nov 02, 2020

CareDx, Burning Rock Biotech Pace Gainers as 360Dx Index Rises 6 Percent in October

Of the 32 companies in the index, 14 firms saw their stock prices increase, while 18 firms' share prices decreased. 

Oct 29, 2020

CareDx Q3 Revenues Up 58 Percent

The company reported $53.4 million in total revenues for the quarter and said testing services revenues rose 61 percent year over year.

Oct 29, 2020

Thermo Fisher Scientific, Terasaki Innovation Center Partner on Transplant Diagnostics Research

Thermo Fisher's transplant diagnostics products include antibody detection assays, post-transplant monitoring solutions, HLA typing products, and lab instrumentation.

Oct 22, 2020

Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

Oct 07, 2020

CareDx Preliminary Q3 Revenues Up 57 Percent

The company said it provided approximately 21,800 total AlloSure and AlloMap patient results during the quarter.

Oct 01, 2020

CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto

CareDx hopes the final LCD for AlloSure Heart will lead to an approval of HeartCare, a combination of AlloSure Heart and AlloMap Heart.

Pages

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.